ICVT in HPV-induced Genital Lesions of Immunocompromised and Immunocompetent Patients

NCT03334240 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

28

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of effect in interim analysis

Conditions

HPV-Induced Genital Lesions

Interventions

DRUG: CLS003
DRUG: Vehicle

Sponsor

Maruho Co., Ltd.